New mutations in NPHP3 and NEK8 are associated with renal-hepatic-pancreatic dysplasia March 26, 2019
RaQualia Pharma, XuanZhu Pharma patent sodium channel protein type 9 subunit alpha blockers March 26, 2019
RSS